---
figid: PMC6323006__nihms-997841-f0002
figtitle: Inhibitors to specific mechanical and metabolic pathways
organisms:
- Homo sapiens
- Chlorocebus aethiops
- Rattus norvegicus
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6323006
filename: nihms-997841-f0002.jpg
figlink: /pmc/articles/PMC6323006/figure/F2/
number: F2
caption: Inhibitors to specific mechanical and metabolic pathways. Experimentally
  proven reversal agents exist for inhibitors of the electron transport chain like
  rotenone (succinate), antimycin A (TMPD, ascorbate), oligomycin (FCCP), and cyanide
  (glucose). 2-Deoxyglucose competitively inhibits the production of glucose via the
  glycolytic pathway. Y-27632 and ML-7 act to inhibit the actin–myosin contraction
  machinery.
papertitle: Platelet biomechanics, platelet bioenergetics, and applications to clinical
  practice and translational research.
reftext: Mitchell J. George, et al. Platelets. 2018 Jul;29(5):431-439.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9521325
figid_alias: PMC6323006__F2
figtype: Figure
redirect_from: /figures/PMC6323006__F2
ndex: cc9b591e-ded3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6323006__nihms-997841-f0002.html
  '@type': Dataset
  description: Inhibitors to specific mechanical and metabolic pathways. Experimentally
    proven reversal agents exist for inhibitors of the electron transport chain like
    rotenone (succinate), antimycin A (TMPD, ascorbate), oligomycin (FCCP), and cyanide
    (glucose). 2-Deoxyglucose competitively inhibits the production of glucose via
    the glycolytic pathway. Y-27632 and ML-7 act to inhibit the actin–myosin contraction
    machinery.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ROCK1
  - ROCK2
  - MYH14
  - MYO6
  - MYO10
  - MYO16
  - MYO19
  - MYH1
  - MYH10
  - MYH11
  - MYH13
  - MYH15
  - MYH16
  - MYH2
  - MYH3
  - MYH4
  - MYH6
  - MYH7
  - MYH7B
  - MYH8
  - MYH9
  - MYO1A
  - MYO1B
  - MYO1C
  - MYO1D
  - MYO1E
  - MYO1F
  - MYO1G
  - MYO1H
  - MYO3A
  - MYO3B
  - MYO5A
  - MYO5B
  - MYO5C
  - MYO7A
  - MYO7B
  - MYO9A
  - MYO9B
  - MYO15A
  - MYO15B
  - MYO18A
  - MYO18B
  - MYL1
  - MYL3
  - MYL4
  - MYL6
  - MYL6B
  - MYL10
  - MYL12A
  - MYL12B
  - MYL2
  - MYL5
  - MYL7
  - MYL9
  - MYL11
  - ATP8A2
  - WDTC1
  - MYLK
  - MYLK2
  - MYLK3
  - HK1
  - GCK
  - HK2
  - HK3
  - SLC25A16
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - Rok
  - sqh
  - Mhc
  - Mlc2
  - ATPsynbeta
  - Atpalpha
  - adp
  - Strn-Mlck
  - Hex-A
  - omm
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - Y-27632
  - ADP
  - ATP
  - glucose
  - 2-deoxyglucose
  - Antimycin A
  - Rotenone
  - TMPD
  - ascorbate
  - Oligomycin
  - Succinate
  - OXIDATIVE
---
